Table 3.
Model | Base Model, n = 1290a | Including Diastolic Function, n = 723a | ||||
---|---|---|---|---|---|---|
PE | SE | P Value | PE | SE | P Value | |
DM | −0.86 | 0.150 | <0.001 | −0.97 | 0.209 | <0.001 |
Age per 10 years | −0.55 | 0.051 | <0.001 | −0.63 | 0.074 | <0.001 |
Female sex | −1.29 | 0.148 | <0.001 | −1.43 | 0.200 | <0.001 |
BMI per kg/m2 | −0.05 | 0.011 | <0.001 | −0.06 | 0.015 | <0.001 |
Lung disease | −0.44 | 0.123 | <0.001 | −0.33 | 0.171 | 0.05 |
LVEF <35% vs ≥50% | −0.63 | 0.188 | <0.001 | −0.55 | 0.267 | 0.04 |
LVEF 35%–50% vs ≥50% | −0.03 | 0.132 | 0.82 | −0.06 | 0.181 | 0.75 |
On statin therapy | 0.23 | 0.169 | 0.18 | 0.25 | 0.220 | 0.25 |
3‐Way interaction term for DM, female sex, BMI | 0.02 | 0.008 | 0.006 | 0.03 | 0.011 | 0.02 |
Abnormal diastolic function | −0.50 | 0.171 | 0.004 |
Abbreviations: BMI, body mass index; DM, diabetes mellitus; LVEF, left ventricular ejection fraction; METs, metabolic equivalents; PE, parameter estimate; SE, standard error of parameter estimate.
Only patients with nonmissing values for covariates included in the model. Parameter estimates indicate the multivariable adjusted absolute mean change in METs from baseline to peak associated with each covariate.